Concepedia

Katja Labitzke

KL

Statistics

Publications

4

Citations

362

H-Index

4

Active since

1997

Affiliations

Amgen (United States)(Current)

Amgen (Germany)

Katja Labitzke is an author at Amgen (United States) specializing in pharmacy, medicinal chemistry, and pharmacology.

Publications per year

1997–2019

4

Publications

4

Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways

Kent Miner, Katja Labitzke, Benxian Liu et al. · Frontiers in Pharmacology · 2019 · 133 citations · Full text

, , +13

Differing roles for short chain fatty acids and GPR43 agonism in the regulation of intestinal barrier function and immune responses

Warren N. D’Souza, Jason Douangpanya, Sharon Mu et al. · PLoS ONE · 2017 · 132 citations · Full text

, , +17

Discovery of 1<i>H</i>-Pyrazol-3(2<i>H</i>)-ones as Potent and Selective Inhibitors of Protein Kinase R-like Endoplasmic Reticulum Kinase (PERK)

Adrian L. Smith, Kristin L. Andrews, Holger Beckmann et al. · Journal of Medicinal Chemistry · 2015 · 84 citations · Full text

, , +16

Gene within gene configuration and expression of the Drosophila melanogaster genes lethal(2)neighbour of tid [l(2)not] and lethal(2)relative of tid [l(2)rot]

Ursula Kurzik‐Dumke, Markus Kaymer, Dietmar Gundacker et al. · Gene · 1997 · 13 citations

, , +4

1–4 of 4